论文部分内容阅读
本文报导以单盲对照法应用鞘内注射抗破伤风血清(ATS)和地塞米松治疗新生儿破伤风的疗效。经临床确诊为新生儿破伤风107例中的99例,分为对照组50例和治疗组49例,治疗组中26例鞘内注射ATS100u,23例同法注射ATS50u。全部病例按临床病情轻重分为Ⅰ～Ⅴ度,两组病情相似,除对照组中2例病情较轻为Ⅱ度外,绝大多数患者均为Ⅳ～Ⅴ度。治疗方法:对照组和治疗组病例均肌肉注射ATS
This article reports the efficacy of intrathecal injection of anti-tetanus serum (ATS) and dexamethasone for neonatal tetanus using a single-blind control. Clinically diagnosed as neonatal tetanus in 107 cases of 99 cases, divided into control group of 50 patients and treatment group, 49 patients in the treatment group, 26 cases of intrathecal injection of ATS100u, 23 cases of the same method of injection of ATS50u. All cases were divided into Ⅰ ~ Ⅴ degree according to the severity of clinical condition. The two groups were similar. Except for 2 cases in the control group, the condition was mild, the majority of patients were Ⅳ ~ Ⅴ degree. Treatment methods: control group and treatment group were intramuscular injection of ATS